13F filer · CIK 1422848 ↗
Capital Research Global Investors
Reported value
$716.87B
+11% on the quarter before
Positions
426
35 new · 68 sold out
Top 10
37.0%
of the value
Est. gain
+$88.10B
on stocks held all quarter
Est. return
+15.1%
on those stocks since Q1 2026
Positions as of Jun 30, 2026, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 56% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2026. Striped tiles are options.
Largest buys
Since Q1 2026, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Meta~$4.91BAdded · 2.7% → 3.1%+8,709,803 shares
- Altria~$2.37BAdded · 0.3% → 0.6%+32,973,712 shares
- Nvidia~$1.94BAdded · 5.2% → 5.7%+9,702,720 shares
- Royal Caribbean Group~$1.91BAdded · 1.2% → 1.5%+6,000,573 shares
- SpaceX~$1.78BNew · 0.0% → 0.2%+10,438,223 shares
- Alphabet~$1.78BAdded · 2.6% → 3.1%+4,980,503 shares
- Dominion Energy~$1.70BAdded · 0.5% → 0.7%+24,879,843 shares
- Oracle~$1.11BAdded · 0.7% → 0.8%+7,606,983 shares
- DoorDash~$1.08BAdded · 0.1% → 0.3%+5,840,368 shares
- Boeing~$1.07BAdded · 0.1% → 0.3%+4,954,050 shares
Largest sells
Since Q1 2026, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Applied Materials~$5.27BCut · 1.6% → 2.2%−7,296,327 shares
- Eli Lilly~$4.51BCut · 3.5% → 3.5%−3,759,507 shares
- UnitedHealth Group~$2.73BCut · 0.7% → 0.6%−6,578,041 shares
- Medtronic~$2.24BCut · 0.6% → 0.1%−28,665,280 shares
- Canadian Nat Res Ltd Med Ter~$1.91BCut · 1.2% → 0.6%−48,364,929 shares
- Halliburton~$1.62BCut · 0.3% → 0.0%−47,687,127 shares
- GE Aerospace~$1.41BCut · 1.5% → 1.6%−3,781,920 shares
- Nextera Energy~$1.37BCut · 0.5% → 0.2%−15,559,435 shares
- Seagate~$1.36BCut · 0.3% → 0.6%−1,409,289 shares
- Apple~$1.34BCut · 2.5% → 2.4%−4,642,016 shares
Holdings
As of Jun 30, 2026. Changes are in shares against Mar 31, 2026, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BroadcomCOM · shares −2.5% · price +22.1% | 6.0% | $42.73B | +$7.72B | ||||||||
| NvidiaCOM · shares +5.0% · price +14.7% | 5.7% | $40.56B | +$4.96B | ||||||||
| MicrosoftCOM · shares −1.4% · price +0.8% | 4.9% | $35.34B | +$272.0M | ||||||||
| AmazonCOM · shares +1.8% · price +14.5% | 4.0% | $28.75B | +$3.56B | ||||||||
| Eli LillyCOM · shares −15% · price +30.4% | 3.5% | $25.04B | +$5.84B | ||||||||
| AlphabetCAP STK CL A · shares +8.7% · price +24.3% | 3.1% | $22.35B | +$4.02B | ||||||||
| MetaCL A · shares +28% · price −1.5% | 3.1% | $22.32B | −$270.4M | ||||||||
| AppleCOM · shares −7.2% · price +14.0% | 2.4% | $17.18B | +$2.11B | ||||||||
| Applied MaterialsCOM · shares −25% · price +111.5% | 2.2% | $16.02B | +$8.45B | ||||||||
| Philip Morris InternationalCOM · shares +5.6% · price +9.4% | 2.1% | $15.24B | +$1.24B | ||||||||
| AlphabetCAP STK CL C · shares +6.4% · price +23.2% | 2.1% | $15.15B | +$2.68B | ||||||||
| GE AerospaceCOM NEW · shares −11% · price +31.7% | 1.6% | $11.56B | +$2.78B | ||||||||
| StarbucksCOM · shares +7.1% · price +14.1% | 1.6% | $11.21B | +$1.29B | ||||||||
| Royal Caribbean GroupCOM · shares +21% · price +15.4% | 1.5% | $10.88B | +$1.20B | ||||||||
| IntelCOM · shares −4.6% · price +216.4% | 1.4% | $10.30B | +$7.04B | ||||||||
| RTXCOM · shares +0.02% · price −1.6% | 1.4% | $9.93B | −$165.4M | ||||||||
| Vertex PharmaceuticalsCOM · shares −7.7% · price +11.2% | 1.4% | $9.68B | +$978.5M | ||||||||
| UberCOM · shares +12% · price +0.3% | 1.3% | $9.43B | +$27.5M | ||||||||
| JPMorgan ChaseCOM · shares +1.2% · price +11.3% | 1.3% | $9.08B | +$910.0M | ||||||||
| Linde plcSHS · shares +8.6% · price +4.7% | 1.3% | $9.05B | +$371.5M | ||||||||
| CiscoCOM · shares +5.0% · price +51.4% | 1.1% | $7.89B | +$2.55B | ||||||||
| Carrier GlobalCOM · shares −8.9% · price +30.3% | 1.1% | $7.78B | +$1.81B | ||||||||
| AbbVieCOM · shares −3.7% · price +15.7% | 1.1% | $7.57B | +$1.03B | ||||||||
| Wells FargoCOM · shares +4.8% · price +3.8% | 0.88% | $6.31B | +$221.0M | ||||||||
| Corning Inc.COM · shares +13% · price +87.9% | 0.88% | $6.31B | +$2.61B | ||||||||
| Total · 426 positions | 100% | $716.87B | +$88.10B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2026 to Q2 2026: 390 stocks held throughout, up $88.10B (+15.1%).
- Applied Materials+$8.45B+112%
- Broadcom+$7.72B+22%
- Intel+$7.04B+216%
- Eli Lilly+$5.84B+30%
- Nvidia+$4.96B+15%
- Accenture−$404.0M−37%
- Abbott Laboratories−$440.2M−12%
- Canadian Nat Res Ltd Med Ter−$1.07B−19%
- ExxonMobil−$1.10B−19%
- Netflix−$1.68B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |